Chembio Diagnostics Receives WHO Prequalification Approval for HIV Self-Test
04 nov. 2019 08h00 HE
|
Chembio Diagnostics, Inc.
MEDFORD, N.Y., Nov. 04, 2019 (GLOBE NEWSWIRE) -- November 4, 2019 - Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today...
Chembio Diagnostics to Report Third Quarter 2019 Financial Results on November 7, 2019
24 oct. 2019 08h00 HE
|
Chembio Diagnostics, Inc.
MEDFORD, NY, Oct. 24, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will...
Chembio Diagnostics Receives WHO Prequalification Approval for Malaysia Facility
17 oct. 2019 08h00 HE
|
Chembio Diagnostics, Inc.
MEDFORD, N.Y., Oct. 17, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced its...
Chembio Diagnostics Announces $20 Million Term Loan with Perceptive Advisors
04 sept. 2019 08h00 HE
|
Chembio Diagnostics, Inc.
MEDFORD, N.Y., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced the closing of...
Chembio Diagnostics to Participate in Upcoming Investor Conferences
27 août 2019 16h05 HE
|
Chembio Diagnostics, Inc.
MEDFORD, N.Y., Aug. 27, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today the company...
Chembio Diagnostics Reports Second Quarter 2019 Financial Results
06 août 2019 16h05 HE
|
Chembio Diagnostics, Inc.
MEDFORD, N.Y., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial...
Chembio Diagnostics to Participate in the Canaccord Genuity Growth Conference
24 juil. 2019 16h05 HE
|
Chembio Diagnostics, Inc.
MEDFORD, N.Y., July 24, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today the company...
Chembio Diagnostics to Report Second Quarter 2019 Financial Results on August 6, 2019
24 juil. 2019 08h00 HE
|
Chembio Diagnostics, Inc.
MEDFORD, N.Y., July 24, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will...
Chembio Diagnostics and Takeda Pharmaceutical Company Enter Collaboration to Develop Point-of-Care Diagnostic Test
18 juil. 2019 08h00 HE
|
Chembio Diagnostics, Inc.
MEDFORD, N.Y., July 18, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care (POC) diagnostics company focused on infectious diseases, today announced that it...
Chembio Diagnostics Receives CE Mark for its Point-of-Care Multiplex Test for Zika, Dengue and Chikungunya
27 juin 2019 09h27 HE
|
Chembio Diagnostics, Inc.
MEDFORD, N.Y. , June 27, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced that is has...